Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy

NCT02508805 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Vertebrogenic Radiculopathy L5, S1

Interventions

DRUG: Neuromultivit
DRUG: Voltaren
DRUG: Sirdalud

Sponsor

Bausch Health Americas, Inc.

Collaborators

[object Object]